Complementary effect of Zingiber officinalis extract and citral in counteracting non allergic nasal congestion by simultaneous loading in ad hoc formulated phospholipid vesicles

Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112170. doi: 10.1016/j.colsurfb.2021.112170. Epub 2021 Oct 20.

Abstract

Natural nasal spray formulations were prepared by using Zingiber officinalis (Z. officinalis) extract and citral synergically loaded into specifically designed phospholipid vesicles. Phospholipid vesicles were selected according to their stabilizing effect on the nasal mucosal barrier, and their effectiveness was further potentiated by the co-loading of Z. officinalis extract as antioxidant and anti-inflammatory agent, and citral as antibacterial molecule. Cryo-TEM images confirmed the formation of morphologically homogeneous and small vesicles, sized around 100 nm, negatively charged (-44 mV) and highly biocompatible (viability ≥100%) as detected by using epithelial cells. The analysis of size distribution of sprayed droplets, average velocity module and spray cone angle suggested a good aptitude of the vesicles to be nebulized and their effective deposition in the nasal cavity. Moreover, vesicles were effectively capable of inhibiting some nasal pathogenic bacteria (i.e. Streptococcus pyogenes, Staphylococcus aureus, Escherichia coli) and to protect the epithelial cells against oxidative damage. The formulations are natural and safe, and all of them have shown promising technological and biological properties suggesting their possible application in the nasal cavity for the treatment of congestions and non-allergic rhinitis.

Keywords: Citral; Z. officinalis; antibacterial activity; antioxidant activity; epithelial cells; phospholipid vesicles.

MeSH terms

  • Acyclic Monoterpenes
  • Antioxidants*
  • Phospholipids*
  • Plant Extracts / pharmacology

Substances

  • Acyclic Monoterpenes
  • Antioxidants
  • Phospholipids
  • Plant Extracts
  • citral